The Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
What are the Historical Growth Trends in the Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market?
The market size of the Benign Prostatic Hyperplasia (BPH) Treatment Devices and Equipment expanded significantly in the past years. It was projected to rise from $1.29 billion in 2024 to $1.38 billion in 2025, with a compound annual growth rate (CAGR) of 7.2%.
What are the 2025 Market Projections: Forecasted Size & Growth Rate for the Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Industry?
The Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment global market is projected to reach $1.8 billion by 2029, growing at a compound annual growth rate (CAGR) of 6.8%.
Download Your Free Sample of the 2025 Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market Report and Uncover Key Trends Now!
What are the Key Growth Drivers Fueling the Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market?
The key drivers in the benign prostatic hyperplasia (bph) treatment devices and equipment market are:
• The advancement in minimally invasive techniques
• The growth of emerging markets
• Support from regulatory bodies
• Emphasis on value-based healthcare
Global Market Segmentation: Identifying Major Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Industry Segments
The benign prostatic hyperplasia (BPH) treatment devices and equipment market covered in this report is segmented –
1) By Product: Resectoscopes, Radiofrequency Ablation Device, Urology Lasers, Prostatic Stents, Implants
2) By Procedure Type: Transurethral Needle Ablation (TUNA), Transurethral Resection Of Prostate (TURP), Transurethral Incision Of Prostate (TUIP), Transurethral Microwave Thermotherapy (TUMT), Laser Surgery, Other Procedure Types
3) By End-User: Hospitals, Ambulatory Surgical Centres (ASC), Clinics, Home
Pre-order the 2025 Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Global Market Report for Fast Delivery & Comprehensive Insights!
What are the Emerging Trends Shaping the Future of the Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market?
The key trends in the benign prostatic hyperplasia (bph) treatment devices and equipment market are:
• The market is showing a progression towards non-surgical and office-based procedures.
• Laser and radiofrequency technologies are rapidly becoming a dominant trend.
• Telemedicine and remote consultation are the rising trends shaping the sector.
• There is an increasing trend in patient education and engagement.
Who Are the Top Competitors & Leading Players in the Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market?
Major companies in the benign prostatic hyperplasia (bph) treatment devices and equipment market are:
• Karl Storz
• Lumenis Ltd.
• Olympus Corporation
• Urologix LLC
• Boston Scientific Inc.
• Endo International plc
• NeoTract Inc.
• OmniGuide Inc.
• Medifocus Inc.
• ProArc Medical Ltd.
• Teleflex Incorporated
• Medtronic plc
• Urotech Devices
• Prostalund Operations AB
• Baxter International
• NxThera Inc.
• Richard Wolf GmbH
• Coloplast A/S
• Siemens Healthineers
• Quest Pharmatech
• Protox Therapeutics
• IntelGenx Technologies Corp
• Astellas Pharma Inc.
• Ipsen S.A.
• Biolitec AG
• BVM Medical
• Convergent Laser Technologies
• Cook Medical
• GreenLight Technologies
• Merit Medical Systems
• Pnn Medical A/S
• PROCEPT BioRobotics
• Prosenex
• ProSolv CardioVascular Inc.
• Quanta System
• Rocamed SAM
• RZ Medizintechnik GmbH
• SRS Medical Systems
• UroShape LLC
• Vertebron Inc.
Regional Dominance: Which Area Leads the Global Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market?
North America was the largest region in the benign prostatic hyperplasia (BPH) treatment devices and equipment market in 2023
